Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility
- PMID: 38537159
- PMCID: PMC11191064
- DOI: 10.1200/JCO.23.01780
Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility
Abstract
Purpose: Pack-year smoking history is an imperfect and biased measure of cumulative tobacco exposure. The use of pack-year smoking history to determine lung cancer screening eligibility in the current US Preventive Services Task Force (USPSTF) guideline may unintentionally exclude many high-risk individuals, especially those from racial and ethnic minority groups. It is unclear whether using a smoking duration cutoff instead of a smoking pack-year cutoff would improve the selection of individuals for screening.
Methods: We analyzed 49,703 individuals with a smoking history from the Southern Community Cohort Study (SCCS) and 22,126 individuals with a smoking history from the Black Women's Health Study (BWHS) to assess eligibility for screening under the USPSTF guideline versus a proposed guideline that replaces the ≥20-pack-year criterion with a ≥20-year smoking duration criterion.
Results: Under the USPSTF guideline, only 57.6% of Black patients with lung cancer in the SCCS would have qualified for screening, whereas a significantly higher percentage of White patients with lung cancer (74.0%) would have qualified (P < .001). Under the proposed guideline, the percentage of Black and White patients with lung cancer who would have qualified for screening increased to 85.3% and 82.0%, respectively, eradicating the disparity in screening eligibility between the groups. In the BWHS, using a 20-year smoking duration cutoff instead of a 20-pack-year cutoff increased the percentage of Black women with lung cancer who would have qualified for screening from 42.5% to 63.8%.
Conclusion: Use of a 20-year smoking duration cutoff instead of a 20-pack-year cutoff greatly increases the proportion of patients with lung cancer who would qualify for screening and eliminates the racial disparity in screening eligibility between Black versus White individuals; smoking duration has the added benefit of being easier to calculate and being a more precise assessment of smoking exposure compared with pack-year smoking history.
Conflict of interest statement
The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (
No potential conflicts of interest were reported.
Figures
Similar articles
-
Persistent race- and sex-based disparities in lung cancer screening eligibility.J Thorac Cardiovasc Surg. 2024 Jul;168(1):248-260.e2. doi: 10.1016/j.jtcvs.2023.10.025. Epub 2023 Oct 18. J Thorac Cardiovasc Surg. 2024. PMID: 37863179
-
Evaluation of Revised US Preventive Services Task Force Lung Cancer Screening Guideline Among Women and Racial/Ethnic Minority Populations.JAMA Netw Open. 2021 Jan 4;4(1):e2033769. doi: 10.1001/jamanetworkopen.2020.33769. JAMA Netw Open. 2021. PMID: 33433600 Free PMC article.
-
Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems.JAMA Netw Open. 2021 Oct 1;4(10):e2128176. doi: 10.1001/jamanetworkopen.2021.28176. JAMA Netw Open. 2021. PMID: 34636916 Free PMC article.
-
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: A Collaborative Modeling Study for the U.S. Preventive Services Task Force [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. Report No.: 20-05266-EF-2. Rockville (MD): Agency for Healthcare Research and Quality (US); 2021 Mar. Report No.: 20-05266-EF-2. PMID: 33750088 Free Books & Documents. Review.
-
Update on Lung Cancer Screening Guideline.Thorac Surg Clin. 2023 Nov;33(4):323-331. doi: 10.1016/j.thorsurg.2023.04.002. Epub 2023 May 31. Thorac Surg Clin. 2023. PMID: 37806735 Review.
Cited by
-
Examination of Firefighting as an Occupational Exposure Criteria for Lung Cancer Screening.Lung. 2024 Oct;202(5):649-655. doi: 10.1007/s00408-024-00736-9. Epub 2024 Aug 20. Lung. 2024. PMID: 39164595
References
-
- de Koning HJ, van der Aalst CM, de Jong PA, et al. : Reduced lung-cancer mortality with volume CT screening in a randomized trial. N Engl J Med 382:503-513, 2020 - PubMed
-
- US Preventive Services Task Force, Krist AH, Davidson KW, et al. : Screening for lung cancer: US Preventive Services Task Force recommendation statement. JAMA 325:962-970, 2021 - PubMed
-
- Liu A, Siddiqi N, Tapan U, et al. : Black race remains associated with lower eligibility for screening using 2021 US Preventive Services Task Force recommendations among lung cancer patients at an urban safety net hospital. J Racial Ethn Health Disparities 10:2836-2843, 2022 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
